ATE280167T1 - Zwischenprodukte und ein verfahren zur herstellung von beta3-adrenergischer rezeptor- agoniste - Google Patents
Zwischenprodukte und ein verfahren zur herstellung von beta3-adrenergischer rezeptor- agonisteInfo
- Publication number
- ATE280167T1 ATE280167T1 AT00305987T AT00305987T ATE280167T1 AT E280167 T1 ATE280167 T1 AT E280167T1 AT 00305987 T AT00305987 T AT 00305987T AT 00305987 T AT00305987 T AT 00305987T AT E280167 T1 ATE280167 T1 AT E280167T1
- Authority
- AT
- Austria
- Prior art keywords
- producing
- receptor agonists
- adrenergic receptor
- intermediate products
- beta3 adrenergic
- Prior art date
Links
- 239000000048 adrenergic agonist Substances 0.000 title 1
- 229940126157 adrenergic receptor agonist Drugs 0.000 title 1
- 102000016959 beta-3 Adrenergic Receptors Human genes 0.000 title 1
- 108010014502 beta-3 Adrenergic Receptors Proteins 0.000 title 1
- 239000013067 intermediate product Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14541799P | 1999-07-23 | 1999-07-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE280167T1 true ATE280167T1 (de) | 2004-11-15 |
Family
ID=22513018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00305987T ATE280167T1 (de) | 1999-07-23 | 2000-07-14 | Zwischenprodukte und ein verfahren zur herstellung von beta3-adrenergischer rezeptor- agoniste |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US6297382B1 (de) |
| EP (1) | EP1078924B1 (de) |
| JP (1) | JP2001048864A (de) |
| AT (1) | ATE280167T1 (de) |
| DE (1) | DE60015036T2 (de) |
| ES (1) | ES2228413T3 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1478625A1 (de) * | 2002-02-27 | 2004-11-24 | Pfizer Products Inc. | Zur herstellung von agonisten des beta-3-adrenergen rezeptors geeignete verfahren und zwischenprodukte |
| US6864268B2 (en) | 2002-02-27 | 2005-03-08 | Pfizer Inc. | β3 adrenergic receptor agonists |
| WO2003072573A1 (en) * | 2002-02-27 | 2003-09-04 | Pfizer Products Inc. | Crystal forms of (r)-2-(2-(4-oxazol-4-yl-phenoxy)-ethylamino)-1-pyridin-3-yl-ethanol |
| EP1424079A1 (de) * | 2002-11-27 | 2004-06-02 | Boehringer Ingelheim International GmbH | Kombination eines beta-3-Rezeptoragonisten und eines Serotonin und/oder Norepinephrin-Wiederaufnahmeinhibitors |
| US7323462B2 (en) * | 2002-12-10 | 2008-01-29 | Pfizer Inc. | Morpholine dopamine agonists |
| US7375100B2 (en) | 2003-06-04 | 2008-05-20 | Pfizer Inc | 2-amino-pyridine derivatives useful for the treatment of diseases |
| GB0312832D0 (en) * | 2003-06-04 | 2003-07-09 | Pfizer Ltd | 2-amino-pyridine derivatives useful for the treatment of diseases |
| US20050026884A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
| US20050113318A1 (en) * | 2003-07-31 | 2005-05-26 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
| US20090285900A1 (en) * | 2003-07-31 | 2009-11-19 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
| EP1786762A2 (de) * | 2004-09-10 | 2007-05-23 | Theravance, Inc. | Amidin-substituierte arylanilinverbindungen |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5019578A (en) | 1987-11-27 | 1991-05-28 | Merck & Co., Inc. | β-adrenergic agonists |
| US5030640A (en) | 1989-01-05 | 1991-07-09 | Merck & Co., Inc. | Novel β-adrenergic agonists and pharmaceutical compositions thereof |
| JPH11504649A (ja) | 1995-05-10 | 1999-04-27 | ファイザー・インコーポレーテッド | β−アドレナリン作働性アゴニスト |
| AR003509A1 (es) | 1995-09-15 | 1998-08-05 | Merck & Co Inc | Sintesis de alfa-cloro o fluoro cetonas. |
| WO1998021184A1 (en) * | 1996-11-14 | 1998-05-22 | Pfizer Inc. | Process for substituted pyridines |
| CA2314925A1 (en) * | 1997-12-19 | 1999-07-01 | Bayer Corporation | Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| US6090942A (en) * | 1998-10-15 | 2000-07-18 | Pfizer Inc. | Process and intermediates for a β3 -adrenergic receptor agonist |
-
2000
- 2000-07-14 DE DE60015036T patent/DE60015036T2/de not_active Expired - Fee Related
- 2000-07-14 EP EP00305987A patent/EP1078924B1/de not_active Expired - Lifetime
- 2000-07-14 AT AT00305987T patent/ATE280167T1/de not_active IP Right Cessation
- 2000-07-14 ES ES00305987T patent/ES2228413T3/es not_active Expired - Lifetime
- 2000-07-20 US US09/620,042 patent/US6297382B1/en not_active Expired - Fee Related
- 2000-07-24 JP JP2000222094A patent/JP2001048864A/ja active Pending
-
2001
- 2001-07-24 US US09/912,016 patent/US6441181B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001048864A (ja) | 2001-02-20 |
| DE60015036T2 (de) | 2006-03-02 |
| US20020045757A1 (en) | 2002-04-18 |
| US6297382B1 (en) | 2001-10-02 |
| EP1078924B1 (de) | 2004-10-20 |
| US6441181B1 (en) | 2002-08-27 |
| EP1078924A1 (de) | 2001-02-28 |
| ES2228413T3 (es) | 2005-04-16 |
| DE60015036D1 (de) | 2004-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE145891T1 (de) | Verfahren zur herstellung von alkoxyiminoacetamid-derivaten und ein zwischenproduckt dafür | |
| ATE282020T1 (de) | Verfahren zur herstellung von 2-aminomalonsäure- derivaten | |
| ATE260919T1 (de) | Zwischenprodukte für die herstellung von pharmazeutischem camptothecin | |
| DE69802231D1 (de) | Verfahren zur Herstellung von Aminobenzol-Derivaten | |
| DE60015036D1 (de) | Zwischenprodukte und ein Verfahren zur Herstellung von beta3-Adrenergischer Rezeptor-Agoniste | |
| ATE127809T1 (de) | Verfahren zur herstellung von verbindungen zur behandlung der gutartigen prostatahypertrophie. | |
| ATE348810T1 (de) | Verfahren zur herstellung von 2-aminomethyl- halogen-pyridinen | |
| ATE191461T1 (de) | Verfahren zur herstellung von alkoxyimino acetamid-derivaten | |
| ATE234288T1 (de) | Verfahren zur herstellung eines buthylthuio- isochinolinderivates und zwischenprodukte dafür | |
| DE69814637D1 (de) | Verfahren zur herstellung von 1-aryl-3-cyclopropyl-1,3-propandionen | |
| DE69714749D1 (de) | Verfahren zur herstellung von 3-amino-2-hydroxy-1-propylethern | |
| ATE132863T1 (de) | Verfahren zur herstellung von 6-(substituiertes aminopropionyl)-derivaten von forskolin | |
| DE60003169D1 (de) | Verfahren zur herstellung von [s-(r*,s*)]-g(b)-[[1-[1-oxo-3-(4-piperidinyl)propyl]-3-piperidinyl]carbonyl] amino]-3-pyridinpropansäurederivate | |
| ATE365152T1 (de) | Verfahren zur herstellung fluorierter benzoesäuren | |
| DE60215193D1 (de) | Stereoselektives verfahren zur herstellung von 6alpha-fluorpregnanen und zwischenprodukten | |
| DE69921795D1 (de) | Verfahren zur herstellung von benzothiophencarbonsäureamid-derivaten | |
| DE69928610D1 (de) | Verfahren zur Herstellung von 2-Carbamoyl-Pyridinen | |
| ATE206109T1 (de) | Verfahren zur herstellung von carbamoylmethylharnstoff-derivaten | |
| ATE223377T1 (de) | Verfahren zur herstellung von difluoracetophenon- derivaten | |
| ATE364600T1 (de) | Verfahren zur herstellung von indol-derivaten und intermediaten dafür | |
| DE69913517D1 (de) | Verfahren zur herstellung einer kristallsuspensionhenonen | |
| ATE212613T1 (de) | Verfahren zur herstellung von 1,7-diaryl- oder 1, 7-diheteroarylheptan-4-olen und synthesezwischenprodukte | |
| ATE177737T1 (de) | Verfahren zur herstellung von 5-arylhydantoin | |
| ATE248841T1 (de) | Verfahren zur herstellung von penicilling- phenylester | |
| DE60008561D1 (de) | Verfahren zur herstellung von oxazol-derivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |